North America Implantable Cardioverter Defibrillators Market Size & Outlook
North America implantable cardioverter defibrillators market, 2018-2030 (US$M)
Related Markets
North America implantable cardioverter defibrillators market highlights
- The North America implantable cardioverter defibrillators market generated a revenue of USD 1,575.7 million in 2023.
- The market is expected to grow at a CAGR of 5.7% from 2024 to 2030.
- In terms of segment, transvenous implantable cardioverter-defibrillators was the largest revenue generating product in 2023.
- Subcutaneous Implantable Cardioverter Defibrillators is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 1,575.7 million |
| Market revenue in 2030 | USD 2,315.3 million |
| Growth rate | 5.7% (CAGR from 2023 to 2030) |
| Largest segment | Transvenous implantable cardioverter-defibrillators |
| Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
Other key industry trends
- In terms of revenue, North America region accounted for 41.4% of the global implantable cardioverter defibrillators market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,236.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Implantable Cardioverter Defibrillators Market Scope
Implantable Cardioverter Defibrillators Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America implantable cardioverter defibrillators market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.82% in 2023. Horizon Databook has segmented the North America implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
Developed markets such as Canada & the U.S. contribute to a significant demand for implantable cardioverter defibrillators ICDs owing to a supportive healthcare ecosystem & favorable reimbursement policy in the region.
Furthermore, the region has a significant prevalence of Cardiovascular Diseases (CVD), contributing to the need for ICDs. In addition, various studies indicated a correlation between patients having an ICD implant & incidence of hypertension.
According to Health and Stroke Foundation of Canada, one in four people in Canada suffers from hypertension. Hence, the significant prevalence of CVD, such as hypertension, aids the market growth. Furthermore, the regional market is supported by the presence of companies such as Medtronic, Abbott, and Boston Scientific Corporation. Medtronic's development of extravascular ICDs (EV-ICDs) is expected to expand opportunities over the forecast period.
Reasons to subscribe to North America implantable cardioverter defibrillators market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America implantable cardioverter defibrillators market databook
-
Our clientele includes a mix of implantable cardioverter defibrillators market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America implantable cardioverter defibrillators market , including forecasts for subscribers. This continent databook contains high-level insights into North America implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America implantable cardioverter defibrillators market size, by country, 2018-2030 (US$M)
North America Implantable Cardioverter Defibrillators Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
